Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.
about
Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new?Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverEndoscopic management of benign biliary stricturesPathogenesis and clinical spectrum of primary sclerosing cholangitis.Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitisHepatobiliary complications of inflammatory bowel disease.Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.Primary sclerosing cholangitis: updates in diagnosis and therapyProgressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders.Indications for non-transplant surgery in primary sclerosing cholangitis.Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation.Primary sclerosing cholangitis: summary of a workshop.Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experienceCurrent Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisPrimary sclerosing cholangitis: diagnosis, prognosis, and management.Endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures.Endoscopy in the management of primary sclerosing cholangitis.Current diagnosis and management of primary sclerosing cholangitis.Clinical features and management of primary sclerosing cholangitis.Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing CholangitisHepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.Primary sclerosing cholangitis: overview and update.Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.Hepatobiliary disorders and complications of inflammatory bowel disease.Benign biliary strictures: current endoscopic management.Primary sclerosing cholangitis: is any treatment worthwhile?Recent insights in primary sclerosing cholangitis.Role of endoscopy in primary sclerosing cholangitis.Advanced therapeutic endoscopist and inflammatory bowel disease: dawn of a new role.Endoscopic management of benign biliary strictures.Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.Benign Biliary Strictures.Systematic review: recurrent autoimmune liver diseases after liver transplantation.Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.Sclerosing cholangitis: pediatric perspective.Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.Update in the management of extraintestinal manifestations of inflammatory bowel disease.Biliary hemorrhage after removal of an expandable metallic stent during liver transplantation.Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective.Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting.
P2860
Q26766651-3D46D6AB-E3E5-4008-B059-685C91E2942EQ26766699-C4682EFF-76FB-4A38-A8DF-47547EE0E610Q26795782-31244C81-661B-4CA3-9FCF-607BF218C631Q33572623-A6A208A1-5DE8-47BF-B3C0-DD01554A15E0Q33795175-2FCFBEEA-5EDA-4D63-A38B-7FA36522DE9DQ33966083-8292A1D8-EB3A-4D91-96E9-CFC66672347CQ34182672-F62F607C-2727-4105-B685-10263CABB06AQ34382536-E262519B-439A-49B4-AA90-E6D2B2971E9EQ35595601-6CBF36AA-B331-4FB9-893E-3F360F8BF105Q36094608-209A3269-DE39-4074-968E-5E3FB7C10003Q36419793-E3269FDD-0385-4A3D-9CAD-B5F15588F1DCQ36581592-4E604A49-BFFD-4B93-B135-40672DCECC64Q36644248-3DA3F12C-2E74-4234-9708-F75AB5F0CC0DQ36752084-A831DCF7-01CE-4542-AE04-D573C0A738A5Q36955053-365E066E-E710-4383-B32A-452081A81ED5Q37156923-8520404C-68B8-4861-A8AB-F95A36E50EF4Q37156930-648704D8-63A1-482D-A0BB-9FD46466E5BCQ37175011-424C8723-FD93-4AD1-A719-EF0214A310A1Q37182946-8DDC0685-3E37-4EA1-B85B-C1E97BBFF189Q37206473-7F765314-1F97-4DA9-B6CA-CEE60208AF56Q37317444-8C379CE5-8560-4B62-AA7F-2E9ADC153296Q37799533-9B498AB5-66F7-4ABD-A17F-EA7F0CBF1B0EQ37866339-6F1200C8-CB5D-4A45-9D19-009714904560Q37905969-B0948E73-78B4-46AD-9AFD-C58E10712011Q37926905-0818933E-4985-4283-980B-50E743DCAF9AQ37962395-1BC4D7E4-3114-455E-B796-878370BCE471Q38019989-D1BD9DB5-2391-466F-993F-2A829B74B4FCQ38164560-B16C71F2-4488-42A9-BF63-9B8874C70990Q38202632-3E536310-4005-48DC-8261-DD10EE561D52Q38329038-B60C9400-02A3-4C51-88D0-ACC444FA0997Q38443665-39A34579-0E2F-4D7A-874B-6E51544B1E30Q39025124-10B1C403-BDCD-481A-B3DB-B2FA30ADEF57Q39037242-6E70E9E1-7322-4AB8-8A8D-01DF2DA16449Q43046283-DE980AA4-10DB-4FA1-86E2-ACC4BF81309CQ43082859-7526B8CD-E2BA-41BE-A3CE-AD39BB42E622Q45151761-61CC3C4D-5670-4890-BCDD-D7222F1E4DF2Q46719222-B58E7106-6FCD-4662-A958-05A1A4B76AB3Q47261927-15CF0DF1-09CC-4C69-9DBC-1F8827B010B4Q50177111-9BD9FE86-F041-4E09-A8D8-718A1DC8B7C3Q52601885-4FF0841A-0B02-4DDC-A49C-CE50755B8B20
P2860
Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@en
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@nl
type
label
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@en
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@nl
prefLabel
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@en
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@nl
P2093
P1476
Impact of endoscopic therapy o ...... rimary sclerosing cholangitis.
@en
P2093
P304
P356
10.1016/S0016-5107(01)70403-8
P407
P577
2001-03-01T00:00:00Z